Publications by authors named "Javle Milind"

Claim this Profile
B
Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials.
Fen Saj, Felicity K Namayanja, Lianchun Xiao, Mitesh J Borad, Robin Kate Kelley, Milind Javle

Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial.
Milind Javle, Christos Fountzilas, Chih-Yi Liao, Meredith Pelster, Daneng Li

Lancet Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response.
Brian De, Prashant Dogra, Mohamed Zaid, Dalia Elganainy, Kevin Sun, Milind Javle

NPJ Syst Biol Appl· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Profiling of Indian Gallbladder Carcinoma: Mutational Insights in a High-Incidence Population.
Moushumi Suryavanshi, Vikas Ostwal, Milind M Javle, Manoj Kumar, Omshree Shetty

JCO Glob Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAPK Pathway Mutations Emerge in Mutant-IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the Interferon Response.
Jinkai Wan, Hatice Duygu Saatcioglu, Haley Ellis, Elia Aguado-Fraile, Qin Xu, Milind Javle

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic Significance.
Yan Zhu, Luisa Maren Solis Soto, Shubham Pant, Eduardo A Vega, Eduardo Vinuela, Milind Javle

Mod Pathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic and clinical outcomes among patients with cholangiocarcinoma receiving pemigatinib with or without history of cancer of unknown primary.
Sumit Verma, Alejandro Hughes, Nicole M Engel-Nitz, Christina Steiger, Shreekant Parasuraman, Milind Javle

Oncologist· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-Institutional Analysis.
Sunyoung S Lee, Dong Hyun Seo, Taek Chung, Daniel Fox, Jaime Ivan Haro-Silerio, Milind Javle

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract Cancers.
Xin Wang, Jaime Ivan Haro-Silerio, Felix Emile Gastonguay Beaudry, Ayelet Borgida, Farnoosh Abbas-Aghababazadeh, Milind M Javle

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Targeting HER2 across Cancer Subtypes - A Pan-tumor Approach.
Taiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav, Aysegul A Sahin, Hui Chen, Milind M Javle

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A GOLP rush in biliary tract cancer: early promise in the quest for curative surgery.
Dan G Duda, Milind Javle

Lancet Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of liver-directed radiotherapy after chemoimmunotherapy for advanced cholangiocarcinoma: an early report from a large tertiary cancer center.
Abdulmoiz Asif, Abdulmoid Asif, Michael K Rooney, Enoch Chang, Felicity Namayanja, Milind Javle

J Gastrointest Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic and socioeconomic disparities in survival outcomes among patients under 65 years with intrahepatic cholangiocarcinoma: a SEER analysis.
Adit Dharia, Lianchun Xiao, Janak Abraham, Fen Saj, Madhulika Eluri, Milind M Javle

J Gastrointest Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience.
Anish J Jain, Mateo Lendoire, Antony Haddad, Ching-Wei D Tzeng, Artem Boyev, Milind Javle

Ann Surg Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant treatment for incidental gallbladder cancer: A systematic review.
Peeyush Varshney, Saphalta Baghmar, Bhawna Sirohi, Ghassan K Abou-Alfa, Hop Tran Cao, Milind Javle

Ann Hepatobiliary Pancreat Surg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial.
Bruno C Odisio, Jessica Albuquerque, Yuan-Mao Lin, Brian M Anderson, Caleb S O'Connor, Milind M Javle

Lancet Gastroenterol Hepatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(adenosine diphosphate ribose) polymerase inhibition in isocitrate dehydrogenase 1 and 2-mutant tumors: Bridging science with the clinic.
Elise Nassif Haddad, Milind M Javle, Timothy A Yap

Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Multiagent Systemic Therapy Approach to Liver Transplantation for Perihilar Cholangiocarcinoma.
Nadine Soliman, Ashton A Connor, Ashish Saharia, Sudha Kodali, Ahmed Elaileh, Milind Javle

Transplant Direct· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplantation for Peri-Hilar and Intrahepatic Cholangiocarcinoma With mTOR Immunosuppression.
Samar Semaan, Ashton A Connor, Ashish Saharia, Sudha Kodali, Ahmed Elaileh, Milind Javle

Transplant Proc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies.
Jibran Ahmed, Anne Knisely, Carlos Torrado, Bettzy Stephen, Yali Yang, Milind Javle

Oncologist· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSR25-160: Evaluating Patient Characteristics, Treatment Patterns, Clinical Outcomes, and Health Care Resource Use in Pemigatinib-Treated Cholangiocarcinoma (CCA) Patients: A Focus on Cancer of Unknown Primary.
Sumit Verma, Sunyoung Lee, Mike Blecker, Alejandro Hughes, Nicole M Engel-Nitz, Milind Javle

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLO25-099: Lenvatinib With Pembrolizumab in Advanced Biliary Tract Cancer.
Kabir Grewal, Shubham Pant, Ian Hu, Madhulika Eluri, Amy An, Milind Javle

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.
Aung Naing, Amit Mahipal, Milind Javle, Judy Wang, Todd M Bauer

J Immunother Precis Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched Analysis.
Yongwoo David Seo, Belkacem Acidi, Andrew Newton, Antony Haddad, Yi-Ju Chiang, Milind Javle

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the value of computed tomography (CT) of the chest in the follow-up of patients with intrahepatic cholangiocarcinoma.
Moamen Abdelaal, Mahmoud Diab, Maguy Farhat, Milind Javle, Mostafa Shehata

J Gastrointest Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis